Catégories
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
DL-Aspartic acid
(22164347 | 617-45-8)
CAS: | 617-45-8 |
---|---|
Formule moléculaire: | HOOCCH2CH(NH2)COOH |
Masse moléculaire: | 133.10 |
Disponibilité: | Vérifier la disponibilité |
---|---|
Téléchargements: | | |
22164347-1kg | 1kg | £93.20 | |
Commande en vrac |
22164347-1kg | 1kg | €130.50 | |
Commande en vrac |
22164347-1kg | 1kg | $139.80 | |
Commande en vrac |
Fiche de données de sécurité
Certificat d'analyse
Détails du produit
Product Code | 22164347 | ||||
Product Name | DL-Aspartic acid | ||||
Categories | Amino Acids | ||||
CAS | 617-45-8 | ||||
Molecular Formula | HOOCCH2CH(NH2)COOH | ||||
Molecular Weight | 133.10 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 29224985 |
Spécifications du produit
Specific rotation | -0.5° - +0.5° | ||||
Loss on Drying | ≤0.20% | ||||
Assay | ≥98% | ||||
Residue on Ignition | ≤0.20% | ||||
Other amino acids | not detectable | ||||
Chloride | ≤0.10% | ||||
Appearance | White crystals or crystalline powder | ||||
Arsenic (as As2O3) | ≤2 ppm | ||||
Heavy Metal (as Pb) | ≤10 ppm |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | none | ||||
Hazard statements |
|
||||
Precautionary statements |
|